Kearny Venture Partners
26
33M
9
2
0.65
7
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main department of described VC is located in the San Francisco.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Kearny Venture Partners, startups are often financed by OrbiMed, Aisling Capital, Venture Investors. The meaningful sponsors for the fund in investment in the same round are Aisling Capital, F-Prime Capital, Venture Investors. In the next rounds fund is usually obtained by OrbiMed, New Enterprise Associates, F-Prime Capital.
Comparing to the other companies, this Kearny Venture Partners performs on 5 percentage points less the average number of lead investments. Deals in the range of 10 - 50 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. Considering the real fund results, this VC is 12 percentage points less often commits exit comparing to other organizations. The important activity for fund was in 2013. The higher amount of exits for fund were in 2014.
This organization was formed by Caley Castelein. Besides them, we counted 2 critical employees of this fund in our database.
Among the most popular portfolio startups of the fund, we may highlight ViewRay, CVRx, Aerpio Pharmaceuticals. Among the most successful fund investment fields, there are Therapeutics, Health Care. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Investments analytics
Analytics
- Total investments
- 26
- Lead investments
- 2
- Exits
- 7
- Follow on index
- 0.65
- Investments by industry
- Health Care (25)
- Biotechnology (21)
- Medical Device (17)
- Therapeutic Devices (9)
- Manufacturing (9) Show 6 more
- Investments by region
-
- United States (24)
- Canada (2)
- Peak activity year
- 2013
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Avg. valuation at time of investment
- 32M
- Group Appearance index
- 1.00
- Avg. company exit year
- 8
- Avg. multiplicator
- 0.15
- Strategy success index
- 0.50
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Akebia Therapeutics | 04 Jun 2013 | Biotechnology, Health Care, Therapeutics | Late Stage Venture | 41M | United States, Massachusetts, Cambridge |
| NextWave Pharmaceuticals | 11 Jan 2011 | Biotechnology, Pharmaceuticals, Health Care, Pharmaceutical | Late Stage Venture | 45M | United States, California, Cupertino |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.